What RxSight, Inc. does.

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing high-quality customized vision to patients following cataract surgery. Our proprietary RxSight ® Light Adjustable Lens system (“RxSight system”) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is comprised of our RxSight Light Adjustable Lens ® (LAL ® /LAL+ ® , collectively the “LAL”), RxSight Light Delivery Device (“LDD™”) and related accessories. The LAL is a premium intraocular lens (“IOL”) made from the proprietary silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (“UV”) light patterns generated by the LDD.

We designed our RxSight system to address limitations of conventional premium IOL technologies by providing doctors with a more precise and adaptable method for achieving desired visual outcomes for their patients. Conventional premium IOLs require patients to select their visual priorities before surgery and accept the optical trade-offs inherent in those choices. Surgeons must rely on a series of preoperative measurements and predictive formulae to determine the appropriate lens power. If the selected power is not optimal, the patient may experience less-than-ideal results that could require a subsequent corneal refractive procedure or other corrective measures to achieve intended vision targets.

Revenue and profit, by fiscal year.

More on RXST.

• RxSight, Inc. summary
• RxSight, Inc. financial statements
• RxSight, Inc. key metrics
• RxSight, Inc. health scores and style box
• RxSight, Inc. earnings
• RxSight, Inc. dividends
• RxSight, Inc. valuation
• RxSight, Inc. ownership and insiders
• RxSight, Inc. peers

Figures from RxSight, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.